This brand name is authorized in Estonia, France, Tunisia, Turkey
The drug CONTRATHION contains one active pharmaceutical ingredient (API):
|
1
Pralidoxime
UNII FQO9PAV523 - PRALIDOXIME METHYL SULFATE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V03AB04 | Pralidoxime | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1284511 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 65724318 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 7273011H |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699839790019 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
